Relx PLC (NYSE:RELX) saw a significant increase in short interest during the month of June. As of June 30th, there was short interest totalling 721,400 shares, an increase of 26.2% from the June 15th total of 571,600 shares. Approximately 0.0% of the company’s stock are sold short. Based on an average daily volume of 855,300 shares, the short-interest ratio is currently 0.8 days.

A number of hedge funds and other institutional investors have recently bought and sold shares of RELX. CWM LLC increased its holdings in Relx by 178.5% during the first quarter. CWM LLC now owns 1,810 shares of the technology company’s stock worth $39,000 after buying an additional 1,160 shares during the last quarter. Ellevest Inc. increased its stake in shares of Relx by 63.8% in the first quarter. Ellevest Inc. now owns 1,944 shares of the technology company’s stock worth $42,000 after purchasing an additional 757 shares in the last quarter. Toronto Dominion Bank increased its stake in shares of Relx by 103.1% in the first quarter. Toronto Dominion Bank now owns 2,640 shares of the technology company’s stock worth $57,000 after purchasing an additional 1,340 shares in the last quarter. Point72 Asset Management L.P. purchased a new position in shares of Relx in the fourth quarter worth about $64,000. Finally, Procyon Private Wealth Partners LLC purchased a new position in shares of Relx in the fourth quarter worth about $90,000. Institutional investors and hedge funds own 3.10% of the company’s stock.

NYSE RELX traded down $0.30 during trading hours on Tuesday, reaching $23.22. 608,900 shares of the company were exchanged, compared to its average volume of 821,077. Relx has a 1 year low of $16.81 and a 1 year high of $27.25. The business’s 50 day simple moving average is $23.44 and its 200-day simple moving average is $23.72. The company has a quick ratio of 0.37, a current ratio of 0.41 and a debt-to-equity ratio of 1.99. The stock has a market capitalization of $45.37 billion, a P/E ratio of 19.51, a P/E/G ratio of 2.88 and a beta of 0.61.

Several analysts have recently commented on RELX shares. Investec upgraded shares of Relx from a “sell” rating to a “hold” rating in a report on Tuesday, June 16th. Credit Suisse Group reiterated an “outperform” rating on shares of Relx in a report on Thursday, March 12th. Barclays reiterated an “overweight” rating on shares of Relx in a report on Tuesday. Zacks Investment Research downgraded shares of Relx from a “strong-buy” rating to a “hold” rating in a report on Wednesday, June 10th. Finally, ValuEngine upgraded shares of Relx from a “sell” rating to a “hold” rating in a report on Friday, March 13th. Six analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $26.00.

About Relx

RELX PLC provides information based-analytics and decision tools for professional and business customers in the United States and internationally. It operates through four segments: Scientific, Technical & Medical; Risk & Business Analytics; and Exhibitions. The Scientific, Technical & Medical segment provides information and analytics to institutions and professionals that enables progress in science, advance healthcare, and performance improvement.

Featured Story: How Do Mutual Funds Work?

Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.